ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.110
-0.240 (-10.21%)
At close: Feb 27, 2026, 4:00 PM EST
2.030
-0.080 (-3.79%)
After-hours: Feb 27, 2026, 7:25 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $276.83 million as of February 27, 2026. Its market cap has increased by 390.52% in one year.
Market Cap
276.83M
Enterprise Value
231.81M
1-Year Change
390.52%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $276.83M, a decrease of -73.79%. That is a compound annual growth rate of -21.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 290.04M |
| Fennec Pharmaceuticals | 289.96M |
| AC Immune | 289.90M |
| Puma Biotechnology | 287.23M |
| Opus Genetics | 286.89M |
| Minerva Neurosciences | 285.61M |
| Inhibikase Therapeutics | 280.40M |
| Abeona Therapeutics | 277.46M |